• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 7
  3. 8
  4. 9
  5. 10
  6. 11
  7. …
  • Omicron BF.7, the dominant subvariant in China COVID-19 outbreak

    China // 22 December, 2022

    BF.7, also known as BA.5.2.1.7...

    COVID-19

  • COVID-19 updates: cases of BF.7 reported

    India // 22 December, 2022

    At four new cases of COVID-19 with BF.7 variant...

    COVID-19

  • Additional COVID-19 booster doses for high-risk groups

    South Africa // 21 December, 2022

    Officials are considering an additional dose of COVID-19 vaccine for...

    COVID-19

  • Study finds surgical mask should not be worn over N95 mask

    20 December, 2022

    An N95 mask with an overlying procedure mask might lead to increased leakages...

    COVID-19

  • Eligibility for COVID-19 oral treatments updated

    Australia // 06 December, 2022

    Health authorities have updated the eligibility for oral treatments...

    COVID-19

  • COVID-19 vaccine approved for children six months and older

    United Kingdom // 06 December, 2022

    Recommendation by the Joint Committee on Vaccination and Immunisation still pending...

    COVID-19

  • Bebtelovimab, COVID-19 treatment no longer authorised by FDA

    United States // 30 November, 2022

    It is not expected to be effective against new dominants subvariants...

    COVID-19

  • WHO COVID-19 weekly reports November 2022

    30 November, 2022

    WHO updates on the global COVID-19 situation continue to show...

    COVID-19

  • Vaccine effectiveness against Omicron variant, WHO

    24 November, 2022

    Evidence based on 53 studies...

    COVID-19

  • Vaccine update - Administration of fourth dose has begun

    Angola // 22 November, 2022

    Fourth dose of COVID-19 vaccine starts...

    COVID-19

  • EMA authorises VidPrevtyn Beta COVID-19 vaccine, updates Spikevax clinical data

    18 November, 2022

    Both vaccines have been approved for use...

    COVID-19

  • COVID-19 cases rise

    Brazil // 18 November, 2022

    A rise in COVID-19 cases due to Omicron sub-variants BQ.1 and XBB ...

    COVID-19

  • Omicron variant BA.2 more likely to elicit symptoms

    United Kingdom // 15 November, 2022

    Study of over 1.5 million people…

    COVID-19

  • COVID-19 Vaccine Update – ATAGI updated recommendations on Pfizer bivalent booster dose in 18 years and older

    Australia // 15 November, 2022

    Updated recommendations for aged 18 years and above...

    COVID-19

  • COVID-19 variants- Cases of BN.1 increasing, BQ.1.1 and BQ.1 are now predominant

    United States // 14 November, 2022

    BA.5 cases are decreasing...

    COVID-19

  • COVID-19 Vaccine Update - Pfizer's BA.4/BA.5 bivalent vaccine to be used

    South Korea // 14 November, 2022

    Will be available from 14 November for people 18 and older...

    COVID-19

  • FDA authorises Kineret for the treatment of COVID-19

    United States // 09 November, 2022

    For use in hospitalised patients...

    COVID-19

  • Increase in COVID-19 cases caused by new Omicron subvariant XBB

    Australia // 09 November, 2022

    Health authorities have reported a rise in COVID-19 case numbers...

    COVID-19

  • ECDC Weekly COVID-19 report shows decreasing trend

    04 November, 2022

    Rates of cases and deaths continue to decrease but more detections of BQ.1 point to expected higher activity in the coming weeks...

    COVID-19

  • WHO COVID-19 weekly reports October 2022

    02 November, 2022

    WHO updates on the global COVID-19 situation continue to show...

    COVID-19

  1. …
  2. 7
  3. 8
  4. 9
  5. 10
  6. 11
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS